Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

$5.9 Billion Apoptosis Assays Market by Product, Detection Technology, Application - Global Forecast to 2023 -

Research and Markets
Posted on: 22 Nov 18

The "Apoptosis Assays Market by Product, Detection Technology, Application - Global Forecast to 2023" report has been added to's offering.

The apoptosis assays market is expected to reach USD 5.9 billion by 2023 from an estimated USD 3.6 billion in 2018, at a CAGR of 10.5%.

The rising incidence and prevalence of chronic and infectious diseases, growing funding for cancer research, growing cell-based research, and development of apoptosis-modulating drugs are the key drivers for market growth. However, high investments required for research and development is expected to restrain the growth of this market to a certain extent during the forecast period.

On the basis of detection technology, the apoptosis assays market is segmented into flow cytometry, cell imaging & microscopy, spectrophotometry, and other detection technologies. The cell imaging & microscopy segment is expected to register the highest CAGR during the forecast period. The increasing adoption of cell imaging and microscopy in diagnostic laboratories, drug discovery applications, and basic research is the major factor driving the growth of this market segment.

On the basis of application, the apoptosis assays market is segmented into drug discovery & development, basic research, stem cell research, and clinical & diagnostic application. The stem cell research applications segment is expected to witness the highest CAGR owing to the increasing number of stem cell research activities and rising investments in stem cell research. Also government initiatives are expected to increase the number of cell-based research activities, which in turn will support the growth of the stem cell application segment.

North America is expected to account for the largest share of the global apoptosis assays market in 2018. On the other hand, the APAC region is expected to witness the highest CAGR during the forecast period, owing to the increasing prevalence of chronic and infectious diseases in this region, large patient population, increasing healthcare spending, and growing interest of key players in APAC countries.

Also, owing to the high growth opportunities in the APAC region, many manufacturers are expanding their global manufacturing bases to this region. With their low-cost manufacturing advantage, China and India are regarded as the most profitable manufacturing and R&D locations by manufacturers.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Industry Insights

7 Apoptosis Assays Market, By Product

8 Apoptosis Assays Market, By Detection Technology

9 Apoptosis Assays Market, By Application

10 Apoptosis Assays Market, By End User

11 Apoptosis Assays Market, By Region

12 Competitive Landscape

13 Company Profiles

  • Abcam PLC
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Bio-Techne Corporation
  • Biotek Instruments
  • Biotium
  • Creative Bioarray (A Part of Creative Dynamics Inc.)
  • Danaher Corporation
  • GE Healthcare
  • GeneCopoeia, Inc.
  • Geno Technology, Inc.
  • Merck KGaA
  • PerkinElmer
  • Promega Corporation
  • Sartorius AG
  • Thermo Fisher Scientific Inc.

For more information about this report visit

View source version on

Business Wire

Last updated on: 22/11/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.